Follow-Up of Thrombin Generation after Prostate Cancer Surgery: Global Test for Increased Hypercoagulability

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Benyo, Matyas ^a   Flasko, Tibor ^a   Molnar, Zsuzsanna ^a   Kerenyi, Adrienne ^a   Batta, Zoltan ^a   Jozsa, Tamas ^a,b   Harsfalvi, Jolan ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRINOGEN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TEST; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; HUMAN TISSUE; HYPERCOAGULABILITY; MALE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; VENOUS THROMBOEMBOLISM;

AGED; BLOOD CELL COUNT; BODY MASS INDEX; FIBRINOGEN; FOLLOW-UP STUDIES; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; STATISTICS, NONPARAMETRIC; THROMBIN; THROMBOPHILIA;

EID: 84870953131     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051299     Document Type: Article

References (21)

1. Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, et al. (2006) A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243: 89-95.
2. Phillips J, Makarawo T, Abedin A, Eaton J, Makar A, (2010) Extended venous thromboembolism prophylaxis after radical pelvic surgery for urological cancers. BJU Int 106: 1110-1111.
3. Galvin DJ, Mulvin D, Quinlan DM, (2004) Thromboprophylaxis for radical prostatectomy: a comparative analysis of present practice between the USA, the UK, and Ireland. Prostate 60: 338-342.
4. AUA (2008) Best practice policy statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery.: 29.
5. Bounameaux H, Perrier A (2006) Diagnosis of venous thromboembolism. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, editors. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Fifth ed. Philadelphia, PA: Lippincott Williams & Wilkins. 1827.
6. Hron G, Kollars M, Binder BR, Eichinger S, Kyrle PA, (2006) Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 296: 397-402.
7. Ay C, Dunkler D, Simanek R, Thaler J, Koder S, et al. (2011) Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the vienna cancer and thrombosis study. J Clin Oncol 29: 2099-2103.
8. Chandler WL, Roshal M, (2009) Optimization of plasma fluorogenic thrombin-generation assays. American Journal of Clinical Pathology 132: 169-179.
9. Al Dieri R, de Laat B, Hemker HC, (2012) Thrombin generation: What have we learned? Blood Rev 26: 197-203.
10. Lutsey PL, Folsom AR, Heckbert SR, Cushman M, (2009) Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study. J Thromb Haemost 7: 1639-1648.
11. Mann KG, (2011) Thrombin generation in hemorrhage control and vascular occlusion. Circulation 124: 225-235.
12. Orfeo T, Gissel M, Butenas S, Undas A, Brummel-Ziedins KE, et al. (2011) Anticoagulants and the propagation phase of thrombin generation. PLoS One 6: e27852.
13. Debaugnies F, Azerad MA, Noubouossie D, Rozen L, Hemker HC, et al. (2010) Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay. Thromb Res 126: 531-535.
14. Chandler WL, (2010) Procoagulant Activity in Trauma Patients. American Journal of Clinical Pathology 134: 90-96.
15. Aleman MM, Gardiner C, Harrison P, Wolberg AS (2011) Differential Contributions of Monocyte- and Platelet-derived Microparticles towards Thrombin Generation and Fibrin Formation and Stability. J Thromb Haemost.
16. Butenas S, van't Veer C, Mann KG, (1999) "Normal" thrombin generation. Blood 94: 2169-2178.
17. Bell CR, Murdock PJ, Pasi KJ, Morgan RJ, (1999) Thrombotic risk factors associated with transurethral prostatectomy. BJU Int 83: 984-989.
18. Haubold K, Rink M, Spath B, Friedrich M, Chun FK, et al. (2009) Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer. Thromb Haemost 101: 1147-1155.
19. Langer F, Chun FK, Amirkhosravi A, Friedrich M, Leuenroth S, et al. (2007) Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers. Thromb Haemost 97: 464-470.
20. Beijers HJ, Ferreira I, Spronk HM, Bravenboer B, Dekker JM, et al. (2010) Body composition as determinant of thrombin generation in plasma: the Hoorn study. Arteriosclerosis, Thrombosis, and Vascular Biology 30: 2639-2647.
21. Thachil J, Gatt A, Martlew V, (2008) Management of surgical patients receiving anticoagulation and antiplatelet agents. Br J Surg 95: 1437-1448.